Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (122)	4/2/1999 9:39:00 AM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 52153

Analysts recommendations as valuators. I just thought that I'd share with the thread a little research I did to find out if the analysts ratings were any indication of stock movement. I simply took the lists from YAHOO of the Biomedical/Gene and Medical Drugs sectors and correlated the analysts mean recommendation with the first quarters stock performances. The correlations were r = .02; .04 respectively. In other words there was no relationship whatsoever between the analysts recommendations and how the stock performed over the first quarter. This really didn't surprise me much. But, it was nice to get an empirical measure of my suspicions that analysts recommendations are next to useless. John de C

To: LLCF who wrote (122)	4/5/1999 1:18:00 PM
From: poodle	Read Replies (1) \| Respond to of 52153

Peter and David Glad you finally explained what you would like in biotech. Hard to get anything for you w/o knowing what you really need.<g> Did I understand you right? You would like Co with Cash = m cap (or about so, you are reasonable, I know), real revenues, long operation history, new exciting technology (better several), and insiders buying these valuable shares. Why didn't you to tell me earlier?<G> techstocks.com Iomed Inc.(IOX [Amex]). STOCK FOR EVERYONE! <G> PS: For biotech Price/Cash=1 is neither unusual nor essentially buy signal. But it's not biotech. Yet. Oooops. Wrong thread, again.<G>